Patents by Inventor Beat Weidmann

Beat Weidmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions for HCV treatment
    Patent number: 7897565
    Abstract: The present invention concerns a pharmaceutical combination comprising a) a first agent which is a non-immunosuppressive cyclophilin-binding cyclosporine, e.g., a compound of formula I and b) a co-agent. Co-agents include, but are not limited to, interferons, a conjugate of interferon, antiviral agents, helicase inhibitors, protease inhibitors, polymerase inhibitors and nucleoside analogs. The instant pharmaceutical combination may be used, e.g., in treating subjects having a flaviviridae infection, e.g., a Hepatitis C infection.
    Type: Grant
    Filed: December 20, 2005
    Date of Patent: March 1, 2011
    Assignee: Novartis AG
    Inventors: Kai Lin, Beat Weidmann
  • Use of Sanglifehrin in HCV
    Publication number: 20090221598
    Abstract: The present invention discloses the use of a cyclophilin-binding compound such as a sanglifehrin for the treatment and prevention of hepatitis C and related diseases such as liver fibrosis, liver cirrhosis and hepatocellular carcinoma.
    Type: Application
    Filed: June 15, 2006
    Publication date: September 3, 2009
    Inventors: Kai Lin, Beat Weidmann, Kaspar Zimmermann
  • COMPOUNDS FOR FLAVIVIRIDAE TREATMENT
    Publication number: 20090214464
    Abstract: Disclosed are non-immunosuppressive cyclophilin-binding cyclosporins, e.g. of formula I, Ia or II as defined herein, having useful properties in the prevention or treatment of Flaviviridae infections and Flaviviridae induced disorders.
    Type: Application
    Filed: December 20, 2005
    Publication date: August 27, 2009
    Inventor: Beat Weidmann
  • Compositions For HCV Treatment
    Publication number: 20090104149
    Abstract: The present invention concerns a pharmaceutical combination comprising a) a first agent which is a non-immunosuppressive cyclophilin-binding cyclosporin, e.g. a compound of formula I and b) a co-agent.
    Type: Application
    Filed: December 20, 2005
    Publication date: April 23, 2009
    Applicant: NOVARTIS AG
    Inventors: Kai Lin, Beat Weidmann
  • Cxcr4 Binding Molecules
    Publication number: 20080234294
    Abstract: This invention relates to the use of a CXCR binding molecules as described in the specification, in WHIM syndrome.
    Type: Application
    Filed: August 17, 2006
    Publication date: September 25, 2008
    Inventors: Jiri Kovarik, Gebhard Thoma, Beat Weidmann, Timothy Wright, Hans-Gunter Zerwes
  • Hydrophilic renin inhibitors, their preparation and use
    Patent number: 5045537
    Abstract: Hydrophilic renin inhibitors, especially of formula ##STR1## wherein R.sub.1, W, o, m, n, A, B, C and D possess the definitions given in claim 2, processes for their production and their use in the treatment of hypertension, cardiac insufficiency and the treatment of diseases caused by retroviruses.
    Type: Grant
    Filed: September 14, 1988
    Date of Patent: September 3, 1991
    Assignee: Sandoz Ltd.
    Inventor: Beat Weidmann